Ghost Tree Capital’s Sierra Oncology SRRA Stock Holding History
Bought
Maintained
Sold
Other funds holding SRRA
Ghost Tree Capital's SRRA Position: Q2 2022 in Review
Ghost Tree Capital sold out of Sierra Oncology (SRRA) in Q2 2022, closing a stake of 325,000 shares — an estimated $10.4M sold.
Ghost Tree Capital first reported a position in SRRA in Q4 2020 and held it in 6 quarters. The position peaked at $10.4M in Q1 2022. 109 funds tracked by Wall St. Rank hold SRRA as of Q2 2022.
- Ghost Tree Capital reported no remaining Sierra Oncology position as of Q2 2022 after selling out during the quarter.
- Ghost Tree Capital sold 325,000 Sierra Oncology shares in Q2 2022, an estimated $10.4M.
- Ghost Tree Capital first reported a position in Sierra Oncology in Q4 2020 and held it in 6 quarters.
- Ghost Tree Capital's Sierra Oncology position peaked at $10.4M in Q1 2022.
- 109 funds tracked by Wall St. Rank held Sierra Oncology as of Q2 2022.
Based on Ghost Tree Capital's 13F filing for Q2 2022, filed 15 Aug 2022.